- Home
- CTSO vs AKYA Comparison
CTSO vs AKYA Comparison
Compare CTSO & AKYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- AKYA
- Stock Information
- Founded
- CTSO 1997
- AKYA 2015
- Country
- CTSO United States
- AKYA United States
- Employees
- CTSO N/A
- AKYA N/A
- Industry
- CTSO Medical/Dental Instruments
- AKYA Medical Specialities
- Sector
- CTSO Health Care
- AKYA Industrials
- Exchange
- CTSO Nasdaq
- AKYA Nasdaq
- Market Cap
- CTSO 52.6M
- AKYA 56.1M
- IPO Year
- CTSO N/A
- AKYA 2021
- Fundamental
- Price
- CTSO $1.03
- AKYA $1.36
- Analyst Decision
- CTSO Buy
- AKYA Hold
- Analyst Count
- CTSO 2
- AKYA 7
- Target Price
- CTSO $5.50
- AKYA $2.51
- AVG Volume (30 Days)
- CTSO 134.9K
- AKYA 464.5K
- Earning Date
- CTSO 08-12-2025
- AKYA 08-04-2025
- Dividend Yield
- CTSO N/A
- AKYA N/A
- EPS Growth
- CTSO N/A
- AKYA N/A
- EPS
- CTSO N/A
- AKYA N/A
- Revenue
- CTSO $35,332,238.00
- AKYA $79,961,000.00
- Revenue This Year
- CTSO $18.34
- AKYA $7.26
- Revenue Next Year
- CTSO $19.82
- AKYA $11.44
- P/E Ratio
- CTSO N/A
- AKYA N/A
- Revenue Growth
- CTSO 15.37
- AKYA N/A
- 52 Week Low
- CTSO $0.71
- AKYA $0.93
- 52 Week High
- CTSO $1.61
- AKYA $3.42
- Technical
- Relative Strength Index (RSI)
- CTSO 49.00
- AKYA 59.70
- Support Level
- CTSO $0.93
- AKYA $1.24
- Resistance Level
- CTSO $1.39
- AKYA $1.40
- Average True Range (ATR)
- CTSO 0.13
- AKYA 0.08
- MACD
- CTSO -0.02
- AKYA 0.01
- Stochastic Oscillator
- CTSO 34.92
- AKYA 90.24
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About AKYA Akoya BioSciences Inc.
Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler (formerly CODEX) and PhenoImager (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics.